FDA should prohibit all menthol flavor additives, compounds, constituents, and ingredients in cigarettes, and should not limit the proposed standard to prohibiting menthol as a “characterizing flavor”

My colleagues at UCSF and other universities and I have submitted this comment to the FDA in response to its proposal to prohibit the use of menthol in cigarettes. A PDF of the comment is here. The Regulations.gov tracking number is l6b-ew3y-c1ye. FDA should prohibit all menthol flavor additives, compounds, constituents, and ingredients in cigarettes,Continue reading “FDA should prohibit all menthol flavor additives, compounds, constituents, and ingredients in cigarettes, and should not limit the proposed standard to prohibiting menthol as a “characterizing flavor””

Since FDA has made a mess of Juul, the health community & Congress should force FDA to ban menthol e-cigs now

The day after FDA denied Juul’s application to continue selling its e-cigarettes on June 23, 2022, Juul sued and obtained an emergency Stay from the US Court of Appeals.  On July 5, the FDA announced that it was issuing its own Administrative Stay and allowed Juul to remain on the market while the FDA considersContinue reading “Since FDA has made a mess of Juul, the health community & Congress should force FDA to ban menthol e-cigs now”

As a matter of health equity and social justice, FDA should immediately finalize and implement the proposed standard for menthol in cigarettes to reduce smoking-attributable deaths and health disparities among African Americans

Several colleagues at UCSF and elsewhere and I submitted this comment to the FDA on its proposed rule to end menthol in cigarettes. A PDF is here; the regulations.gov tracking number is l4s-xj6c-9kba. As a matter of health equity and social justice, FDA should immediately finalize and implement the proposed standard for menthol in cigarettesContinue reading “As a matter of health equity and social justice, FDA should immediately finalize and implement the proposed standard for menthol in cigarettes to reduce smoking-attributable deaths and health disparities among African Americans”

White House OKs FDA moving forward on reducing nicotine in cigs; FDA can and should ban menthol ecigs now

On June 21, 2022, the Biden Administration announced that FDA would be moving forward to develop a product standard limiting nicotine in cigarettes and other combusted tobacco products to nonaddictive levels. FDA has been formally considering such a rule for a long time. In 2018, FDA solicited public comment on such a rule. At thatContinue reading “White House OKs FDA moving forward on reducing nicotine in cigs; FDA can and should ban menthol ecigs now”

FDA should not give the tobacco companies more time to submit public comments about the proposed rule ending characterizing flavors in cigars

My colleagues and I submitted this public comment to FDA urging them not to extend the comment period for the rule ending flavored cigars, as the tobacco companies have requested. According to the FDA’s own analysis granting the 3 month delay would cost 60 lives and an additional $1.17-$1.43 billion in costs. The industry hasContinue reading “FDA should not give the tobacco companies more time to submit public comments about the proposed rule ending characterizing flavors in cigars”

Support for cigarette menthol ban and cigar flavor ban; need to ban menthol as an ingredient not just as a characterizing flavor and to eliminate exceptions for some tobacco products (Statement at June 13, 2022 FDA Listening Session)

My name is Stanton Glantz.  I am a retired Professor of Medicine at the University of California San Francisco and was the principal investigator of the UCSF Tobacco Center of Regulatory Science. The FDA did an excellent job of summarizing the science on the effects of menthol to build a justification for ending the useContinue reading “Support for cigarette menthol ban and cigar flavor ban; need to ban menthol as an ingredient not just as a characterizing flavor and to eliminate exceptions for some tobacco products (Statement at June 13, 2022 FDA Listening Session)”

Cutting phase-in for cig menthol ban from 1 year to 90 days will prevent 265,000 kids from smoking and 12,000 premature deaths

FDA’s draft rule ending menthol cigarettes proposes giving tobacco companies a year to clear menthol cigarettes off the market. FDA requested public comment on shortening the phase in 90 days. My UCSF and Stanford colleagues and I submitted this public comment (PDF version) supporting a 90 day phase in. We noted that FDA’s own analysisContinue reading “Cutting phase-in for cig menthol ban from 1 year to 90 days will prevent 265,000 kids from smoking and 12,000 premature deaths”

FDA granting the tobacco companies’ request to extend the public comment period its menthol cigarette ban will lead to 58,000 more smokers and 2,700 more deaths

FDA has invited public comment on its well-justified rule to get rid of menthol cigarettes. Even though dealing with menthol cigarettes has been being considered and debated for 13 years, the tobacco companies have told FDA they need more time to prepare their comments and asked that the comment period be extended for 60 days.Continue reading “FDA granting the tobacco companies’ request to extend the public comment period its menthol cigarette ban will lead to 58,000 more smokers and 2,700 more deaths”

FDA does JT/Logic’s work for it to justify authorizing 3 of its ENDS

On March 24, 2022 FDA authorized the sale of three electronic nicotine delivery systems distributed by Japan Tobacco’s US company Logic Technology Development, – two conventional e-cigarettes and one heated tobacco product.  FDA withheld the Technical Project Lead (TPL) report that provides the scientific justifications for its decision. Thanks to my colleague Lauren Lempert filingContinue reading “FDA does JT/Logic’s work for it to justify authorizing 3 of its ENDS”

FDA proposed updating its HPHC list in 2019; it needs to finish the job

One of the nerdy, but very important, parts of the FDA tobacco product regulatory process is the list of “Hazardous and Potentially Hazardous Compounds” (HPHC) list that FDA released in 2012. This list contains 93 bad chemicals — mostly carcinogens — that FDA identified as important when assessing the risks of tobacco products. It hasContinue reading “FDA proposed updating its HPHC list in 2019; it needs to finish the job”